119 related articles for article (PubMed ID: 11788240)
1. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
Monti JM; Jantos H; Monti D
Eur Neuropsychopharmacol; 2002 Feb; 12(1):47-55. PubMed ID: 11788240
[TBL] [Abstract][Full Text] [Related]
2. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
Monti JM; Jantos H; Monti D; Alvariño F
Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
[TBL] [Abstract][Full Text] [Related]
4. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
Monti JM; Jantos H; Lagos P
Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
[TBL] [Abstract][Full Text] [Related]
5. Serotonin control of sleep-wake behavior.
Monti JM
Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
[TBL] [Abstract][Full Text] [Related]
6. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Jantos H
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2003 Oct; 478(2-3):121-30. PubMed ID: 14575796
[TBL] [Abstract][Full Text] [Related]
8. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.
Monti JM; Monti D
Life Sci; 2000 Apr; 66(21):1999-2012. PubMed ID: 10823340
[TBL] [Abstract][Full Text] [Related]
9. A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.
Monti JM; Jantos H
Int J Neuropsychopharmacol; 2005 Mar; 8(1):75-86. PubMed ID: 15327697
[TBL] [Abstract][Full Text] [Related]
10. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Leopoldo M; Jantos H
Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
Monti JM; Jantos H; Catenaccio V; Xavier S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
[TBL] [Abstract][Full Text] [Related]
12. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.
Monti JM; Jantos H
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1189-95. PubMed ID: 16713054
[TBL] [Abstract][Full Text] [Related]
13. Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonists.
Monti JM; Jantos H; Monti D
Behav Brain Res; 2001 Aug; 123(1):23-35. PubMed ID: 11377727
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
[TBL] [Abstract][Full Text] [Related]
15. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
Monti JM; Jantos H; Schechter LE
Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
[TBL] [Abstract][Full Text] [Related]
16. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
Monti JM
Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
[TBL] [Abstract][Full Text] [Related]
17. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
Sakai K; Crochet S
Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008
[TBL] [Abstract][Full Text] [Related]
18. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
Monti JM; Jantos H
Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
[TBL] [Abstract][Full Text] [Related]
19. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
[TBL] [Abstract][Full Text] [Related]
20. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]